arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Celularity Inc

CELU

$0.74 ▼ -0.06 (-7.95%) at close

8 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Moderately Bearish

auto_awesome

Analytical Summary

Celularity Inc faces fundamental challenges. On the positive side, Return on Common Equity (%) remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $18.9M

Dividend Yield —

Revenue Growth -51.0% ↘

Op. Margin -230.9% ↘

ROIC 161.1% ↗

FCF / Share $-0.52 ↘

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

8-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$26.55M

↓ -51.0% —

Net Income Profit after all expenses

$-91.72M

↓ -58.4% —

Operating Margin Operating profit as % of sales

-230.9%

↓ -226.4% 0th

FCF / Share Free cash flow per share

$-0.52

↓ -72.7% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

100

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	-51.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-738%)	138.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1626%)	26.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+234%)	-15.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-297%)	49.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+518%)	—	—	—
EPS Growth YoY (%)	-36.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	76.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—	—	—
Net Income Growth YoY (%)	-58.4% Weak Weak Year-over-year change in net income	70.5% Excellent Excellent Year-over-year change in net income	N/M	N/M	51.9% Excellent Excellent Year-over-year change in net income	N/M	—	—
FCF Growth YoY (%)	-72.7% Weak ↑ Weak Improving Year-over-year change in free cash flow	86.6% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	78.2% Excellent Excellent Year-over-year change in free cash flow	-489.8% Weak Weak Year-over-year change in free cash flow	—	—	—	—
Revenue CAGR 3Y (%)	13.9% Good ↓ Good Declining Compound annual revenue growth over 3 years	36.5% Excellent Excellent Compound annual revenue growth over 3 years	16.8% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—
Revenue CAGR 5Y (%)	13.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	-230.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1639%)	-70.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-572%)	—	-142.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1049%)	—	—	—	—
Effective Tax Rate (%) (%)	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	21.0% Fair Fair Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-345.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2979%)	-106.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-990%)	—	79.0% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+558%)	-469.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4011%)	—	—	—
FCF Margin (%) (%)	-49.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-12.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-174.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—
FCF / Net Income (x)	0.14x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.11x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.20x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-10.08x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.16x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.44x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.44x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	161.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-342.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-469.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-109.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	28.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	-8.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-57.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-28.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-133.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-35.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-0.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	241.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1506%)	—	—	7.1% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-52%)	-100.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-771%)	39.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+161%)	50.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+235%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Debt to Equity (x)	—	—	0.42x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-30%)	0.19x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-68%)	—	—	—	—
Interest Coverage (x)	-24.50x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-266.38x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-179.21x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-746.98x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-6.17M	$-738.00K	$17.00M	$23.64M	$-37.24M	$-54.31M	$-917.01K	$-24.71K
Debt / EBITDA (x)	—	—	-0.09x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.33x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$1.04	$2.48	$1.28	$1.28	$0.32	—	—	—
Basic EPS, GAAP (USD)	$-3.59	$-2.64	$-11.02	$1.01	$-1.49	—	—	—
Free Cash Flow per Share (USD)	$-0.52	$-0.30	$-2.23	$-10.23	$-1.73	—	—	—
Book Value per Share (USD)	$-1.32	$0.39	$2.11	$13.36	$0.80	$-28.68	—	—
Tangible Book Value per Share (USD)	$-1.84	$-0.34	$1.17	$-2.81	$-1.18	$-42.10	—	—
Basic Weighted Avg Shares (shares)	25.60M	21.89M	17.81M	13.99M	67.06M	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$-68.44M	$-33.12M	$-47.51M	$-28.59M	$32.88M	$45.48M	$780.06K	$-125.85K
Total Equity (USD)	$-38.06M	$8.84M	$40.96M	$198.90M	$99.42M	$-531.40M	$5.00M	$23.90K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$26.55M	$54.22M	$22.77M	$17.98M	$21.34M	$14.28M	—	—
Depreciation Expense (USD)	$7.29M	$7.92M	$9.32M	$9.44M	$8.82M	$8.17M	—	—
Net Income, GAAP (USD)	$-91.72M	$-57.89M	$-196.29M	$14.19M	$-100.12M	$-208.23M	$2.51M	—
Operating Cash Flow (USD)	$-13.25M	$-6.40M	$-38.69M	$-137.88M	$-110.10M	$-63.19M	$-1.10M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 8 years · 32 quarters

Celularity Inc

Analytical Summary

8-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CELU with peers